Publications by the researcher in collaboration with Rafael Cantón Moreno (86)

2023

  1. The Impact of Colistin Resistance on the Activation of Innate Immunity by Lipopolysaccharide Modification

    Infection and immunity, Vol. 91, Núm. 2, pp. e0001223

  2. Automatic Discrimination of Species within the Enterobacter cloacae Complex Using Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and Supervised Algorithms

    Journal of clinical microbiology, Vol. 61, Núm. 4, pp. e0104922

2022

  1. The Human Mycobiome in Chronic Respiratory Diseases: Current Situation and Future Perspectives

    Microorganisms, Vol. 10, Núm. 4

  2. Correction to: Evaluation of CHROMagar™-Serratia agar, a new chromogenic medium for the detection and isolation of Serratia marcescens (European Journal of Clinical Microbiology & Infectious Diseases, (2021), 40, 12, (2593-2596), 10.1007/s10096-021-04328-w)

    European Journal of Clinical Microbiology and Infectious Diseases

  3. Strain-specific predation of Bdellovibrio bacteriovorus on Pseudomonas aeruginosa with a higher range for cystic fibrosis than for bacteremia isolates

    Scientific Reports, Vol. 12, Núm. 1

  4. Imitation of β-lactam binding enables broad-spectrum metallo-β-lactamase inhibitors

    Nature Chemistry, Vol. 14, Núm. 1, pp. 15-24

2021

  1. Emergence and Persistence over Time of Carbapenemase-Producing Enterobacter Isolates in a Spanish University Hospital in Madrid, Spain (2005-2018)

    Microbial Drug Resistance, Vol. 27, Núm. 7, pp. 895-903

  2. Characterization of carbapenemase-producing Serratia marcescens and whole-genome sequencing for plasmid typing in a hospital in Madrid, Spain (2016-18)

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 1, pp. 110-116

  3. Propensity-Score Analysis Reveals that Sex is Not a Prognostic Factor for Mortality in Intensive Care Unit-Admitted Patients with Septic Bacteremia

    International Journal of Infectious Diseases, Vol. 110, pp. 36-44

  4. Murepavadin antimicrobial activity against and resistance development in cystic fibrosis Pseudomonas aeruginosa isolates

    The Journal of antimicrobial chemotherapy, Vol. 76, Núm. 4, pp. 984-992

  5. Long-term impact of suppressive antibiotic therapy on intestinal microbiota

    Genes, Vol. 12, Núm. 1, pp. 1-13

  6. Evaluation of CHROMagar™-Serratia agar, a new chromogenic medium for the detection and isolation of Serratia marcescens

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 40, Núm. 12, pp. 2593-2596

  7. Anti-biofilm activity of murepavadin against cystic fibrosis Pseudomonas aeruginosa isolates

    Journal of Antimicrobial Chemotherapy, Vol. 76, Núm. 10, pp. 2578-2585

  8. An Immunologic Compatibility Testing Was Not Useful for Donor Selection in Fecal Microbiota Transplantation for Ulcerative Colitis

    Frontiers in Immunology, Vol. 12

2020

  1. Long-term docosahexaenoic acid (DHA) supplementation in cystic fibrosis patients: a randomized, multi-center, double-blind, placebo-controlled trial

    Prostaglandins Leukotrienes and Essential Fatty Acids, Vol. 162

  2. A publicly accessible database for clostridioides difficile genome sequences supports tracing of transmission chains and epidemics

    Microbial Genomics, Vol. 6, Núm. 8, pp. 1-13

2019

  1. Whole-genome sequencing reveals nosocomial Clostridioides difficile transmission and a previously unsuspected epidemic scenario

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Low and constant micafungin concentrations may be sufficient to lead to resistance mutations in FKS2 gene of Candida glabrata

    Medical Mycology, Vol. 56, Núm. 7, pp. 903-906

  2. Emergence of ESBL-producing Escherichia coli ST131-C1-M27 clade colonizing patients in Europe

    Journal of Antimicrobial Chemotherapy, Vol. 73, Núm. 11, pp. 2973-2980

  3. Distinct Genetic Diversity of Carbapenem-Resistant Acinetobacter baumannii from Colombian Hospitals

    Microbial Drug Resistance, Vol. 24, Núm. 1, pp. 48-54